Authors


Pamela S. Kallmerten, PhD, DNP, RN, CNL

Latest:

Challenges with mHealth Apps for Depression and Suicide Prevention

Learn what potential challenges come with mHealth apps and how to overcome them to best fit patient needs.


Hanz Dismer, LCSW

Latest:

How Abortion Bans Harm Mental Health

Does a lack of abortion access fuel mental illness by exacerbating stress, poverty, and domestic violence? Learn more here.


Charles S. Burke, MD

Latest:

Valuable Insights to Share With the Psychiatric Community

Psychiatrists have valuable insights on political and societal issues that can be shared with the psychiatric community.



Azadeh Zamiri, MD

Latest:

HIV-Associated Neurocognitive Disorder: An Updated Pathophysiology

In this CME, learn more about the pathophysiology of HIV-associated neurocognitive disorder and to review the research and various tools used to aid in the diagnosis.


Paul Doghramji, MD, FAAFP

Latest:

Increasing Awareness of Insomnia

Drs Paul Doghramji and Leslie Citrome share approaches to communicate with patients and increase awareness of insomnia disorder


David Lehman, MD

Latest:

Tales of Overconfidence: 3 Stories to Refine Psychiatry

These 3 stories offer a lesson in humility to psychiatry.


Peter J. Tyrer

Latest:

The Doctors Who Cut Out Your Appendix to Fix Your Head

In the early 20th century, British and American doctors looked for the causes of mental illnesses elsewhere in the body, with gruesome results.


Marvin J. Bittner, MD

Latest:

Vaccination Avoidance as Risk Avoidance Driven by Fear and Helplessness

We seek to reduce vaccine side effects—but what about the social media-compounded fears of anti-COVID vaccination?


Yael Danieli, PhD

Latest:

We Will Remember Dancing: A Message From a Child Shoah Survivor to the Young 10/7 Survivors

Dance/movement therapy has proven to be effective in treating children with trauma, making dance something that can change the way a child develops psychologically.


Itamar Shapira, MD

Latest:

Unraveling the Threads of Trepidation: The Prevalence and Evolving Contours of Anxiety and Traumatic Stress

An understanding of evolving risk factors and pathophysiology is vital to optimal clinical management of anxiety disorders and PTSD.


Janeé M. Steele, PhD

Latest:

Using CBT to Empower Black Patients

Judith S. Beck, PhD, and Janeé M. Steele, PhD, engage in a conversation about how clinicians from all backgrounds can address issues of race in session and also empower Black patients with a sense of personal pride in their identities.


Carmen Andreescu, MD

Latest:

Supporting Ukrainian Mental Health

“The acute and long-term psychological consequences of this tragedy will require large-scale aid.”


Amir Inamdar MBBS, DNB (Psych), MFPM

Latest:

Here's to a Psychedelic Revolution

Research is underway to make psychedelics agents a treatment option for psychiatric disorders.


Christina P.C. Borba, PhD, MPH

Latest:

Perspectives on Global Women’s Mental Health

This diverse group of women came together to explore the challenges in treating mental illness in patients who identify as female.


Ron Southwick

Latest:

AMA President Addresses the State of Medicine

“We didn’t pick this political fight, but we will stand up for our patients, for the policies of this House, and for our profession.”


Lubna Khawaja, MD

Latest:

Breaking the Spell: Fighting Myths About COVID-19 Vaccination

The vaccine needs to be appropriately framed: as a benefit, not a risk.


Savitha Prabhu, MScN

Latest:

Media & Mental Health: The Need for More Credible Information

Has the media’s obsession with the COVID-19 pandemic put global mental health at risk?


Harneet Kaur, MD

Latest:

Winning the Battle: Reflections of a Psychiatrist Living With BPAD

One professional psychiatrist shares his account of living with bipolar affective disorder.


Joshua Robak, MD

Latest:

Zuranolone for the Treatment of Adults With Major Depressive Disorder

This randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day in MDD led to significantly greater improvements in depressive symptoms when compared with placebo.


Stefan G. Hofmann, PhD

Latest:

D-cycloserine for Anxiety Disorders: What Psychiatrists Need to Know

D-cycloserine may help patients with anxiety disorders, or it might make their anxiety worse. Find out how to use it safely.


Elizabeth Dowling

Latest:

Mount Sinai Study Shows That Human Beliefs About Drugs Could Have Dose-Dependent Effects on the Brain

"Our findings provide a mechanistic explanation for the well-known variations in individual responses to drugs and suggest that subjective beliefs could be a direct target for the treatment of substance use disorders," said Xiaosi Gu, PhD, senior author of the study.


Nour Awwad

Latest:

Shattered Self: Schizophrenia Suffering, Beyond Logic and Reason

How can looking at the suffering of patients with schizophrenia through a psychodynamic lens help clinicians develop effective interventions and treatment plans?


Andrew N. Wilner, MD, FACP, FAAN

Latest:

Exploring the Underwater World

A psychiatrist discusses his favorite hobby of scuba diving.


Jon A. Van Loon, MD

Latest:

Surviving Vaccine Hesitancy Together

What is the mindset of “anti-vaxxers,” and how can you connect with them as a clinician?


Jonathan S. Comer, PhD

Latest:

Issues in Regulating DTx

We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?


Lisa A. Eramo, MA

Latest:

Facilitating Collections From Patients

Collecting fees is essential, but it can be uncomfortable and even difficult. What strategies can you use to ease the burden?




Rahul Biljani, MD

Latest:

Racism, Policing, and COVID-19 Disparities: We Need Action!

This moment in history cannot be lost. When you ask us if we are okay, be prepared to hear us say we are not . . . and never have been. Then be prepared to do more.

© 2025 MJH Life Sciences

All rights reserved.